Market Overview:
The global aminoglycoside antibiotics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for aminoglycoside antibiotics in veterinary applications, and growing awareness about the benefits of these antibiotics. Based on type, the global aminoglycoside antibiotics market is segmented into neomycin, tobramycin, gentamicin, amikacin, paromomycin and kanamycin. Gentamicin held the largest share of this market in 2017 owing to its high efficacy against a wide range of pathogens and its low toxicity profile. Based on application, the global aminoglycoside antibiotics market is segmented into veterinary applications (poultry & swine), respiratory infections (pneumonia & bronchitis), urinary tract infections (UTIs) & pelvic disease infections (gynecological infections), and neonatal sepsis. UTI & pelvic disease infection was the largest application segment in 2017 due to high prevalence rates of UTIs across all age groups and rising awareness about pelvic inflammatory diseases among women worldwide.
Product Definition:
Aminoglycoside antibiotics are a class of antibiotics that work by inhibiting the synthesis of proteins in bacteria. They are important for treating serious infections caused by bacteria that are resistant to other types of antibiotics.
Neomycin:
Neomycin, also known as Streptomycin, is an aminoglycoside antibiotic used to treat bacterial infections. It works by killing the bacteria that carry out infection by binding to their cell walls and inhibiting protein synthesis. Neomycin was first discovered in the early 1950s and was introduced into medical use in 1955.
Tobramycin:
Tobramycin is an aminoglycoside antibiotic used to treat bacterial infections in the lungs, kidneys, and urinary tract. It works by killing the bacteria that causes infection. Tobramycin has a wide range of applications including treatment of ventilator-associated pneumonia (VAP), chronic bronchitis, and acute respiratory failure.
Application Insights:
The veterinary application segment led the market in 2017 and is projected to expand at a CAGR of XX% over the forecast period. Aminoglycosides are used for treatment and prevention of animal diseases, mainly bacterial infections that affect animals including poultry, swine, dogs and horses. The emergence of resistant bacteria has been a major concern for healthcare professionals; however, aminoglycoside antibiotics have few side effects on humans if used properly under medical supervision as they are not considered to be superinfective drugs.
Animal health authorities across the globe continue to recommend usage of these antibiotics as their use does not contribute towards increasing prevalence rates of resistance genes in bacteria associated with them such as Methicillin-resistant Staphylococcus aureus (MRSA) or Escherichia coli (E coli). Furthermore, extensive R&D activities carried out by pharmaceutical companies pertaining to new drug development for animal health purposes is expected to fuel product demand over the coming years.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to maintain its position over the forecast period. The presence of key manufacturers, coupled with rising healthcare expenditure, favorable government initiatives, and increasing awareness about antibiotic resistance are some factors that can be attributed to this dominance. Furthermore, China has one of the largest livestock industries globally which also contributes significantly to regional growth.
The European market for aminoglycoside antibiotics is anticipated to witness a CAGR of XX% from 2018 to 2030 owing their growing use in veterinary medicine as well as human medicine applications such as UTI & Pelvic Inflammation and Respiratory Tract Infection (RTI). In addition, high prevalence of multi-drug resistant tuberculosis along with stringent regulatory guidelines by EMEA countries are driving growth in this region.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the global aminoglycoside antibiotics market. This is because infections caused by bacteria are becoming more common and resistant to traditional antibiotics, which has led to an increase in the demand for aminoglycoside antibiotics.
- Rising prevalence of multidrug-resistant bacteria: The rising prevalence of multidrug-resistant bacteria is another key factor that is expected to drive the growth of the global aminoglycoside antibiotics market in the coming years. This is because these strains are resistant to most traditional antibiotics, making aminoglycosides one of few remaining treatment options available for patients suffering from such infections.
- Growing awareness about antibiotic resistance: There has been a growing awareness about antibiotic resistance in recent years, which has led to an increased demand for novel and effective antimicrobial drugs such as aminoglycoside antibiotics. This trend is likely to continue in the coming years, thereby propelling the growth of this market segment further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Aminoglycoside Antibiotics Market Research Report
By Type
Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Kanamycin
By Application
Veterinary, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis
By Companies
Britannica, Novartis Pharmaceuticals, Merck, Kremoint Pharma, Medson Pharmaceuticals, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
199
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Aminoglycoside Antibiotics Market Report Segments:
The global Aminoglycoside Antibiotics market is segmented on the basis of:
Types
Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Kanamycin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Britannica
- Novartis Pharmaceuticals
- Merck
- Kremoint Pharma
- Medson Pharmaceuticals
- Allergan
Highlights of The Aminoglycoside Antibiotics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Neomycin
- Tobramycin
- Gentamicin
- Amikacin
- Paromomycin
- Kanamycin
- By Application:
- Veterinary
- Respiratory
- UTI & Pelvic Disease
- Neonatal Sepsis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aminoglycoside Antibiotics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aminoglycoside antibiotics are a type of antibiotic that is derived from the amino acid aminoguanidine. These antibiotics work by killing bacteria by disrupting their cell wall. Aminoglycoside antibiotics are most commonly used to treat infections caused by bacteria such as pneumonia, meningitis, and urinary tract infections.
Some of the major players in the aminoglycoside antibiotics market are Britannica, Novartis Pharmaceuticals, Merck, Kremoint Pharma, Medson Pharmaceuticals, Allergan.
The aminoglycoside antibiotics market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aminoglycoside Antibiotics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aminoglycoside Antibiotics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aminoglycoside Antibiotics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aminoglycoside Antibiotics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aminoglycoside Antibiotics Market Size & Forecast, 2020-2028
4.5.1 Aminoglycoside Antibiotics Market Size and Y-o-Y Growth
4.5.2 Aminoglycoside Antibiotics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Neomycin
5.2.2 Tobramycin
5.2.3 Gentamicin
5.2.4 Amikacin
5.2.5 Paromomycin
5.2.6 Kanamycin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Veterinary
6.2.2 Respiratory
6.2.3 UTI & Pelvic Disease
6.2.4 Neonatal Sepsis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aminoglycoside Antibiotics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aminoglycoside Antibiotics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Neomycin
9.6.2 Tobramycin
9.6.3 Gentamicin
9.6.4 Amikacin
9.6.5 Paromomycin
9.6.6 Kanamycin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Veterinary
9.10.2 Respiratory
9.10.3 UTI & Pelvic Disease
9.10.4 Neonatal Sepsis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Neomycin
10.6.2 Tobramycin
10.6.3 Gentamicin
10.6.4 Amikacin
10.6.5 Paromomycin
10.6.6 Kanamycin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Veterinary
10.10.2 Respiratory
10.10.3 UTI & Pelvic Disease
10.10.4 Neonatal Sepsis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Neomycin
11.6.2 Tobramycin
11.6.3 Gentamicin
11.6.4 Amikacin
11.6.5 Paromomycin
11.6.6 Kanamycin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Veterinary
11.10.2 Respiratory
11.10.3 UTI & Pelvic Disease
11.10.4 Neonatal Sepsis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Neomycin
12.6.2 Tobramycin
12.6.3 Gentamicin
12.6.4 Amikacin
12.6.5 Paromomycin
12.6.6 Kanamycin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Veterinary
12.10.2 Respiratory
12.10.3 UTI & Pelvic Disease
12.10.4 Neonatal Sepsis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Neomycin
13.6.2 Tobramycin
13.6.3 Gentamicin
13.6.4 Amikacin
13.6.5 Paromomycin
13.6.6 Kanamycin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Veterinary
13.10.2 Respiratory
13.10.3 UTI & Pelvic Disease
13.10.4 Neonatal Sepsis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aminoglycoside Antibiotics Market: Competitive Dashboard
14.2 Global Aminoglycoside Antibiotics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Britannica
14.3.2 Novartis Pharmaceuticals
14.3.3 Merck
14.3.4 Kremoint Pharma
14.3.5 Medson Pharmaceuticals
14.3.6 Allergan
